Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.

A Nebraska-based investment group recently paid $19.75 million for much of Rochester's Broadway Commons complex that houses ...

TD Cowen lowered the firm’s price target on DaVita (DVA) to $154 from $157 and keeps a Hold rating on the shares. The firm notes the company beat ...